Related Experiment Videos
Review article: current therapeutic options for radiation proctopathy
J J Hong1, W Park, E D Ehrenpreis
1Gastroenterology Division, Department of Medicine, University of Chicago, Pritzker School of Medicine, Chicago, IL 60637, USA.
Alimentary Pharmacology & Therapeutics
|September 13, 2001
Summary
Radiation proctopathy, a common complication of pelvic radiation, presents with various rectal symptoms. Current treatments vary, with sucralfate and formalin showing promise for bleeding, but more research is needed.
Area of Science:
- Gastroenterology
- Oncology
- Radiation Oncology
Background:
- Radiation proctopathy is a frequent complication after pelvic radiation therapy for malignancies.
- Symptoms include rectal bleeding, urgency, pain, and altered bowel habits.
- Existing treatments offer varied efficacy and are often based on limited evidence.
Purpose of the Study:
- To review current treatment options for radiation proctopathy.
- To evaluate the effectiveness of pharmacological, endoscopic, and surgical interventions.
- To highlight the need for further research and standardized management protocols.
Main Methods:
- Review of pharmacological agents (e.g., 5-ASA, sucralfate, formalin, misoprostol).
- Analysis of endoscopic techniques (e.g., Nd:YAG laser, argon plasma coagulation).
- Consideration of surgical interventions for refractory cases.
Main Results:
- Sucralfate and formalin show efficacy in controlling rectal bleeding.
- Misoprostol and oral sucralfate may aid in preventing acute and chronic symptoms.
- Argon plasma coagulation is a safe endoscopic option for bleeding lesions.
- Surgery is reserved for severe, refractory cases.
Conclusions:
- Management of radiation proctopathy is challenging due to a lack of robust clinical trials.
- Further research is essential to establish evidence-based treatment guidelines.
- Improved education and research are needed for optimal patient care.